Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholder's Equity (Tables)

Stockholder's Equity (Tables)

3 Months Ended

Feb. 28, 2015

Significant Option Groups Outstanding and Exercisable Option and its Price and Contractual Life

Significant option groups exercisable at February 28, 2015 and related price and contractual life information are as follows:


	Outstanding						Exercisable
Range of Exercise Prices	Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Outstanding		Weighted Average Exercise Price
$0.42 to $1.00		2,500		.45	$	0.68		2,500	$	0.68
$1.01 to $ 2.00		469,264		6.20	$	1.72		468,431	$	1.72
$2.01 to $ 3.00		519,667		5.11	$	2.53		504,873	$	2.53

		991,431		5.61	$	2.14		975,804	$	2.14

Summary of Non-Vested Options

A summary of the status of the Company’s non-vested options as of February 28, 2015, and changes during the three months ended February 28, 2015, is presented below:


	Options			Weighted Average Grant-Date Fair Value
Non-vested at November 30, 2014		27,083		$	1.64
Granted		—			—
Vested		(11,456	)		1.67
Forfeited		—			—

Non-vested at February 28, 2015		15,627		$	1.61

Service-Based Vesting Condition Options [Member]

Stock Option Activity for Options

Stock option activity for the three months ended February 28, 2015, was as follows:


	Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value
Outstanding at November 30, 2014		997,266	$	2.14		5.84	$	661,466
Granted		—		—				—
Exercised		—		—				—
Expired/forfeited		5,835		2.26				1,125

Outstanding at February 28, 2015		991,431	$	2.14		5.61	$	414,408

Exercisable at February 28, 2015		975,804	$	2.14		5.61	$	412,827